Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02884297Phase 3Completed
Phase 3, open-label, single-arm trial of sulfur hexafluoride in pregnancy, sponsored by CHR Metz-Thionville. Primary endpoint: Measurement of signal strength at 1 day. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02884297.